In addition, patients with high NUSAP1 expression are more likely to develop lymph node metastasis, and these patients primarily have typical pathological types of PTC, which further illustrates the potential of NUSAP1 to serve as a prognostic marker. Here, NUSAP1 is linked to metastatic malignant neoplasm in the lymph nodes.